BMI is one signal, not the full story. ABCD provides deeper risk insight.
BMI limitations
BMI does not directly measure body fat function, fat distribution, or organ-level metabolic consequences.
Definition
In ABCD care, BMI is considered alongside clinical markers, complications, and disease stage.
What to include beyond BMI
- Waist and adiposity pattern
- Glucose and lipid markers
- Blood pressure and liver health
- Complication screening by system
Bottom line
Better decisions come from a full clinical picture, not a single number.
Frequently Asked Questions
Is BMI useless?
No. It is useful as a screening signal, but not a standalone diagnostic endpoint.
What improves assessment quality?
Combining anthropometrics with metabolic markers and complication review.
Can BMI miss high-risk patients?
Yes, especially when adiposity distribution or metabolic dysfunction is not obvious.